{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T14:14:23Z","timestamp":1779286463821,"version":"3.51.4"},"reference-count":163,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s10495-026-02284-4","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T06:53:36Z","timestamp":1776668016000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Necroptosis in pancreatic cancer: Molecular mechanisms and therapeutic implications"],"prefix":"10.1007","volume":"31","author":[{"given":"Yu-Jie","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Wen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ti","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang-Shen","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Dong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"2284_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263","journal-title":"CA Cancer J Clin"},{"key":"2284_CR2","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424","journal-title":"CA Cancer J Clin"},{"key":"2284_CR3","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12943-019-1029-8","volume":"18","author":"Y Gong","year":"2019","unstructured":"Gong Y, Fan Z, Luo G, Yang C et al (2019) The role of necroptosis in cancer biology and therapy. Mol Cancer 18:100","journal-title":"Mol Cancer"},{"key":"2284_CR4","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1101\/gad.348523.121","volume":"35","author":"GL Beatty","year":"2021","unstructured":"Beatty GL, Werba G, Lyssiotis CA, Simeone DM (2021) The biological underpinnings of therapeutic resistance in pancreatic cancer. Genes Dev 35:940\u2013962","journal-title":"Genes Dev"},{"key":"2284_CR5","doi-asserted-by":"publisher","first-page":"5513","DOI":"10.1200\/JCO.2009.24.2446","volume":"27","author":"D Cunningham","year":"2009","unstructured":"Cunningham D, Chau I, Stocken DD, Valle JW et al (2009) Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer. J Clin Oncol 27:5513\u20135518","journal-title":"J Clin Oncol"},{"key":"2284_CR6","doi-asserted-by":"publisher","first-page":"4504","DOI":"10.3390\/ijms20184504","volume":"20","author":"S Zeng","year":"2019","unstructured":"Zeng S, P\u00f6ttler M, Lan B, Gr\u00fctzmann R et al (2019) Chemoresistance in pancreatic cancer. Int J Mol Sci 20:4504","journal-title":"Int J Mol Sci"},{"key":"2284_CR7","doi-asserted-by":"crossref","unstructured":"Giansante V, Stati G, Sancilio S, Guerra E et al (2023) The dual role of necroptosis in pancreatic ductal adenocarcinoma. Int J Mol Sci 24:12633","DOI":"10.3390\/ijms241612633"},{"key":"2284_CR8","doi-asserted-by":"crossref","unstructured":"He R, Wang Z, Dong S, Chen Z et al (2022) Understanding Necroptosis in Pancreatic Diseases. Biomolecules 12:828","DOI":"10.3390\/biom12060828"},{"key":"2284_CR9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cell.2023.11.044","volume":"187","author":"K Newton","year":"2024","unstructured":"Newton K, Strasser A, Kayagaki N, Dixit VM (2024) Cell death. Cell 187:235\u2013256","journal-title":"Cell"},{"key":"2284_CR10","doi-asserted-by":"publisher","first-page":"10240","DOI":"10.3390\/ijms262010240","volume":"26","author":"N Sendtner","year":"2025","unstructured":"Sendtner N, Seitz R, Brandl N, M\u00fcller M et al (2025) Reactive oxygen species across death pathways: gatekeepers of apoptosis, ferroptosis, pyroptosis, paraptosis, and beyond. Int J Mol Sci 26:10240","journal-title":"Int J Mol Sci"},{"key":"2284_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12929-023-00956-w","volume":"30","author":"SF Wang","year":"2023","unstructured":"Wang SF, Tseng LM, Lee HC (2023) Role of mitochondrial alterations in human cancer progression and cancer immunity. J Biomed Sci 30:61","journal-title":"J Biomed Sci"},{"key":"2284_CR12","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/s41575-021-00486-6","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen X, Zeh HJ, Kang R, Kroemer G et al (2021) Cell death in pancreatic cancer: from pathogenesis to therapy. Nat Rev Gastroenterol Hepatol 18:804\u2013823","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2284_CR13","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13045-022-01392-3","volume":"15","author":"X Tong","year":"2022","unstructured":"Tong X, Tang R, Xiao M, Xu J et al (2022) Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and Cuproptosis research. J Hematol Oncol 15:174","journal-title":"J Hematol Oncol"},{"key":"2284_CR14","doi-asserted-by":"publisher","first-page":"216738","DOI":"10.1016\/j.canlet.2024.216738","volume":"588","author":"M Gu","year":"2024","unstructured":"Gu M, Liu Y, Xin P, Guo W et al (2024) Fundamental insights and molecular interactions in pancreatic cancer: pathways to therapeutic approaches. Cancer Lett 588:216738","journal-title":"Cancer Lett"},{"key":"2284_CR15","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H et al (2025) Cancer statistics, 2025. CA Cancer J Clin 75:10\u201345","journal-title":"CA Cancer J Clin"},{"key":"2284_CR16","doi-asserted-by":"publisher","first-page":"1547582","DOI":"10.3389\/fcell.2025.1547582","volume":"13","author":"V Rapozzi","year":"2025","unstructured":"Rapozzi V, Comuzzi C, Giorgio ED, Xodo LE (2025) KRAS and NRF2 drive metabolic reprogramming in pancreatic cancer cells: the influence of oxidative and nitrosative stress. Front Cell Dev Biol 13:1547582","journal-title":"Front Cell Dev Biol"},{"key":"2284_CR17","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.3390\/cancers14092153","volume":"14","author":"JK Messex","year":"2022","unstructured":"Messex JK, Adams KLA, Hawkins WG, DeNardo D et al (2022) Oncogenic Kras-mediated cytokine CCL15 regulates pancreatic cancer cell migration and invasion through ROS. Cancers 14:2153","journal-title":"Cancers"},{"key":"2284_CR18","doi-asserted-by":"publisher","first-page":"7372","DOI":"10.1245\/s10434-025-17400-y","volume":"32","author":"K Kobayashi","year":"2025","unstructured":"Kobayashi K, Sawada Y, Sahara K, Kikuchi Y et al (2025) Clinical relevance of high-grade pancreatic intraepithelial neoplasia at the pancreatic transection margin in patients with pancreatic ductal adenocarcinoma. Ann Surg Oncol 32:7372\u20137381","journal-title":"Ann Surg Oncol"},{"key":"2284_CR19","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","volume":"395","author":"JD Mizrahi","year":"2020","unstructured":"Mizrahi JD, Surana R, Valle JW, Shroff RT (2020) Pancreatic cancer. Lancet 395:2008\u20132020","journal-title":"Lancet"},{"key":"2284_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3892\/or.2021.8182","volume":"46","author":"X Chen","year":"2021","unstructured":"Chen X, Liu F, Xue Q, Weng X et al (2021) Metastatic pancreatic cancer: mechanisms and detection. Oncol Rep 46:231","journal-title":"Oncol Rep"},{"key":"2284_CR21","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.ijsu.2018.01.041","volume":"52","author":"SAM Karim","year":"2018","unstructured":"Karim SAM, Abdulla KS, Abdulkarim QH, Rahim FH (2018) The outcomes and complications of pancreaticoduodenectomy (Whipple procedure): cross sectional study. Int J Surg 52:383\u2013387","journal-title":"Int J Surg"},{"key":"2284_CR22","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.1016\/j.ijsu.2015.06.062","volume":"21","author":"G Romano","year":"2015","unstructured":"Romano G, Agrusa A, Galia M, Di Buono G et al (2015) Whipple\u2019s pancreaticoduodenectomy: surgical technique and perioperative clinical outcomes in a single center. Int J Surg 21:S68\u2013S71","journal-title":"Int J Surg"},{"key":"2284_CR23","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1097\/SLA.0000000000000263","volume":"259","author":"W Kimura","year":"2014","unstructured":"Kimura W, Miyata H, Gotoh M, Hirai I et al (2014) A pancreaticoduodenectomy risk model derived from 8575 cases from a National single-race population (Japanese) using a web-based data entry system: the 30-day and in-hospital mortality rates for pancreaticoduodenectomy. Ann Surg 259:773\u2013780","journal-title":"Ann Surg"},{"key":"2284_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.drup.2015.10.002","volume":"23","author":"Y Binenbaum","year":"2015","unstructured":"Binenbaum Y, Na\u2019ara S, Gil Z (2015) Gemcitabine resistance in pancreatic ductal adenocarcinoma. Drug Resist Updat 23:55\u201368","journal-title":"Drug Resist Updat"},{"key":"2284_CR25","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1200\/JCO.20.01364","volume":"38","author":"DPS Sohal","year":"2020","unstructured":"Sohal DPS, Kennedy EB, Cinar P, Conroy T et al (2020) Metastatic pancreatic cancer: ASCO guideline update. J Clin Oncol 38:3217\u20133230","journal-title":"J Clin Oncol"},{"key":"2284_CR26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.cell.2011.11.031","volume":"148","author":"L Sun","year":"2012","unstructured":"Sun L, Wang H, Wang Z, He S et al (2012) Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148:213\u2013227","journal-title":"Cell"},{"key":"2284_CR27","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.celrep.2014.02.035","volume":"7","author":"A Hadji","year":"2014","unstructured":"Hadji A, Ceppi P, Murmann AE, Brockway S et al (2014) Death induced by CD95 or CD95 ligand elimination. Cell Rep 7:208\u2013222","journal-title":"Cell Rep"},{"key":"2284_CR28","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.chom.2012.01.016","volume":"11","author":"JW Upton","year":"2019","unstructured":"Upton JW, Kaiser WJ, Mocarski ES (2019) DAI\/ZBP1\/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA. Cell Host Microbe 11:290\u2013297","journal-title":"Cell Host Microbe"},{"key":"2284_CR29","doi-asserted-by":"publisher","first-page":"31268","DOI":"10.1074\/jbc.M113.462341","volume":"288","author":"WJ Kaiser","year":"2013","unstructured":"Kaiser WJ, Sridharan H, Huang C, Mandal P et al (2013) Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. J Biol Chem 288:31268\u201331279","journal-title":"J Biol Chem"},{"key":"2284_CR30","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.molcel.2011.06.011","volume":"43","author":"M Feoktistova","year":"2011","unstructured":"Feoktistova M, Geserick P, Kellert B, Dimitrova DP et al (2011) cIAPs block ripoptosome formation, a RIP1\/Caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol Cell 43:449\u2013463","journal-title":"Mol Cell"},{"key":"2284_CR31","doi-asserted-by":"publisher","first-page":"E3109","DOI":"10.1073\/pnas.1301218110","volume":"110","author":"RJ Thapa","year":"2013","unstructured":"Thapa RJ, Nogusa S, Chen P, Maki JL et al (2013) Interferon-induced RIP1\/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases. Proc Natl Acad Sci U S A 110:E3109\u2013E3118","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2284_CR32","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.molcel.2009.10.013","volume":"36","author":"TL Haas","year":"2009","unstructured":"Haas TL, Emmerich CH, Gerlach B, Schmukle AC et al (2009) Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol Cell 36:831\u2013844","journal-title":"Mol Cell"},{"key":"2284_CR33","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/nrm2970","volume":"11","author":"P Vandenabeele","year":"2010","unstructured":"Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G (2010) Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 11:700\u2013714","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2284_CR34","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.critrevonc.2011.08.004","volume":"82","author":"W Wu","year":"2012","unstructured":"Wu W, Liu P, Li J (2012) Necroptosis: an emerging form of programmed cell death. Crit Rev Oncol Hematol 82:249\u2013258","journal-title":"Crit Rev Oncol Hematol"},{"key":"2284_CR35","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/s41586-019-1770-6","volume":"575","author":"M Fritsch","year":"2019","unstructured":"Fritsch M, G\u00fcnther SD, Schwarzer R, Albert MC et al (2019) Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis. Nature 575:683\u2013687","journal-title":"Nature"},{"key":"2284_CR36","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0092-8674(03)00521-X","volume":"114","author":"O Micheau","year":"2003","unstructured":"Micheau O, Tschopp J (2003) Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114:181\u2013190","journal-title":"Cell"},{"key":"2284_CR37","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/ni914","volume":"4","author":"A Cauwels","year":"2003","unstructured":"Cauwels A, Janssen B, Waeytens A, Cuvelier C et al (2003) Caspase inhibition causes hyperacute tumor necrosis factor-induced shock via oxidative stress and phospholipase A2. Nat Immunol 4:387\u2013393","journal-title":"Nat Immunol"},{"key":"2284_CR38","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.cell.2009.05.021","volume":"137","author":"S He","year":"2009","unstructured":"He S, Wang L, Miao L, Wang T et al (2009) Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-\u03b1. Cell 137:1100\u20131111","journal-title":"Cell"},{"key":"2284_CR39","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/nature20558","volume":"540","author":"J Lin","year":"2016","unstructured":"Lin J, Kumari S, Kim C, Van TM et al (2016) RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation. Nature 540:124\u2013128","journal-title":"Nature"},{"key":"2284_CR40","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1101\/gad.223321.113","volume":"27","author":"K Moriwaki","year":"2013","unstructured":"Moriwaki K, Chan FK (2013) RIP3: a molecular switch for necrosis and inflammation. Genes Dev 27:1640\u20131649","journal-title":"Genes Dev"},{"key":"2284_CR41","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.cell.2012.06.019","volume":"150","author":"J Li","year":"2012","unstructured":"Li J, McQuade T, Siemer AB, Napetschnig J et al (2012) The RIP1\/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell 150:339\u2013350","journal-title":"Cell"},{"key":"2284_CR42","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1097\/00006676-200401000-00023","volume":"28","author":"A Fukunaga","year":"2004","unstructured":"Fukunaga A, Miyamoto M, Cho Y, Murakami S et al (2004) CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma. Pancreas 28:e26\u2013e31","journal-title":"Pancreas"},{"key":"2284_CR43","doi-asserted-by":"publisher","first-page":"101696","DOI":"10.1016\/j.xcrm.2024.101696","volume":"5","author":"MS Alam","year":"2024","unstructured":"Alam MS, Gaida MM, Witzel HR, Otsuka S et al (2024) TNFR1 signaling promotes pancreatic tumor growth by limiting dendritic cell number and function. Cell Rep Med 5:101696","journal-title":"Cell Rep Med"},{"key":"2284_CR44","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nchembio.83","volume":"4","author":"A Degterev","year":"2008","unstructured":"Degterev A, Hitomi J, Germscheid M, Ch\u2019ilen M et al (2008) Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 4:313\u2013321","journal-title":"Nat Chem Biol"},{"key":"2284_CR45","doi-asserted-by":"publisher","first-page":"106697","DOI":"10.1016\/j.phrs.2023.106697","volume":"189","author":"F Shi","year":"2023","unstructured":"Shi F, Yuan L, Wong T, Li Q et al (2023) Dimethyl fumarate inhibits necroptosis and alleviates systemic inflammatory response syndrome by blocking the RIPK1-RIPK3-MLKL axis. Pharmacol Res 189:106697","journal-title":"Pharmacol Res"},{"key":"2284_CR46","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.jare.2025.01.040","volume":"77","author":"L Yu","year":"2025","unstructured":"Yu L, Guo Q, Li Y, Mao M et al (2025) CHMP4C promotes pancreatic cancer progression by inhibiting necroptosis via the RIPK1\/RIPK3\/MLKL pathway. J Adv Res 77:653\u2013668","journal-title":"J Adv Res"},{"key":"2284_CR47","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.canlet.2017.09.002","volume":"410","author":"MJ Cekay","year":"2017","unstructured":"Cekay MJ, Roesler S, Frank T, Knuth AK et al (2017) Smac mimetics and type II interferon synergistically induce necroptosis in various cancer cell lines. Cancer Lett 410:228\u2013237","journal-title":"Cancer Lett"},{"key":"2284_CR48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.canlet.2016.05.036","volume":"380","author":"S Hannes","year":"2016","unstructured":"Hannes S, Abhari BA, Fulda S (2016) Smac mimetic triggers necroptosis in pancreatic carcinoma cells when caspase activation is blocked. Cancer Lett 380:31\u201338","journal-title":"Cancer Lett"},{"key":"2284_CR49","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41419-021-04014-x","volume":"12","author":"S Hannes","year":"2021","unstructured":"Hannes S, Karlowitz R, van Wijk SJL (2021) The Smac mimetic BV6 cooperates with STING to induce necroptosis in apoptosis-resistant pancreatic carcinoma cells. Cell Death Dis 12:816","journal-title":"Cell Death Dis"},{"key":"2284_CR50","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/bcpt.13694","volume":"130","author":"Q Zhao","year":"2022","unstructured":"Zhao Q, Zheng Y, Lv X, Gong J et al (2022) IMB5036 inhibits human pancreatic cancer growth primarily through activating necroptosis. Basic Clin Pharmacol Toxicol 130:375\u2013384","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2284_CR51","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nature12656","volume":"503","author":"M Okada-Iwabu","year":"2013","unstructured":"Okada-Iwabu M, Yamauchi T, Iwabu M, Honma T et al (2013) A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity. Nature 503:493\u2013499","journal-title":"Nature"},{"key":"2284_CR52","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/s41419-018-0851-z","volume":"9","author":"M Akimoto","year":"2018","unstructured":"Akimoto M, Maruyama R, Kawabata Y, Tajima Y et al (2018) Antidiabetic adiponectin receptor agonist adiporon suppresses tumour growth of pancreatic cancer by inducing RIPK1\/ERK-dependent necroptosis. Cell Death Dis 9:804","journal-title":"Cell Death Dis"},{"key":"2284_CR53","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1002\/med.21399","volume":"36","author":"M Yan","year":"2016","unstructured":"Yan M, Wang C, He B, Yang M et al (2016) Aurora-A kinase: a potent oncogene and target for cancer therapy. Med Res Rev 36:1036\u20131079","journal-title":"Med Res Rev"},{"key":"2284_CR54","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3389\/fonc.2015.00278","volume":"5","author":"V Bavetsias","year":"2015","unstructured":"Bavetsias V, Linardopoulos S (2015) Aurora kinase inhibitors: current status and outlook. Front Oncol 5:278","journal-title":"Front Oncol"},{"key":"2284_CR55","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12943-020-01305-3","volume":"20","author":"R Du","year":"2021","unstructured":"Du R, Huang C, Liu K, Li X et al (2021) Targeting AURKA in cancer: molecular mechanisms and opportunities for cancer therapy. Mol Cancer 20:15","journal-title":"Mol Cancer"},{"key":"2284_CR56","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1053\/j.gastro.2017.07.036","volume":"153","author":"Y Xie","year":"2017","unstructured":"Xie Y, Zhu S, Zhong M, Yang M et al (2017) Inhibition of Aurora kinase A induces necroptosis in pancreatic carcinoma. Gastroenterology 153:1429\u20131443.e5","journal-title":"Gastroenterology"},{"key":"2284_CR57","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/ptr.1100","volume":"16","author":"X Chen","year":"2002","unstructured":"Chen X, Yang L, Oppenheim JJ, Howard OMZ (2002) Cellular pharmacology studies of shikonin derivatives. Phytother Res 16:199\u2013209","journal-title":"Phytother Res"},{"key":"2284_CR58","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.bcp.2014.01.041","volume":"88","author":"Y Wang","year":"2014","unstructured":"Wang Y, Zhou Y, Jia G, Han B et al (2014) Shikonin suppresses tumor growth and synergizes with gemcitabine in a pancreatic cancer xenograft model: involvement of NF-\u03baB signaling pathway. Biochem Pharmacol 88:322\u2013333","journal-title":"Biochem Pharmacol"},{"key":"2284_CR59","first-page":"5507","volume":"9","author":"C Chen","year":"2017","unstructured":"Chen C, Xiao W, Huang L, Yu G et al (2017) Shikonin induces apoptosis and necroptosis in pancreatic cancer via regulating the expression of RIP1\/RIP3 and synergizes the activity of gemcitabine. Am J Transl Res 9:5507\u20135517","journal-title":"Am J Transl Res"},{"key":"2284_CR60","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.canlet.2010.03.003","volume":"295","author":"HJ Maier","year":"2010","unstructured":"Maier HJ, Schmidt-Strassburger U, Huber MA, Wiedemann EM et al (2010) NF-kappaB promotes epithelial-mesenchymal transition, migration and invasion of pancreatic carcinoma cells. Cancer Lett 295:214\u2013228","journal-title":"Cancer Lett"},{"key":"2284_CR61","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.3390\/nu17193090","volume":"17","author":"W Du","year":"2025","unstructured":"Du W, Xu R, Chen P, Wen J et al (2025) Salecan suppresses pancreatic cancer progression by promoting necroptosis via the RIPK1\/MLKL pathway. Nutrients 17:3090","journal-title":"Nutrients"},{"key":"2284_CR62","doi-asserted-by":"publisher","first-page":"4675","DOI":"10.18632\/oncotarget.22563","volume":"9","author":"E Zielinska","year":"2018","unstructured":"Zielinska E, Zauszkiewicz-Pawlak A, Wojcik M, Inkielewicz-Stepniak I (2018) Silver nanoparticles of different sizes induce a mixed type of programmed cell death in human pancreatic ductal adenocarcinoma. Oncotarget 9:4675\u20134697","journal-title":"Oncotarget"},{"key":"2284_CR63","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/adma.201303001","volume":"26","author":"GY Tonga","year":"2014","unstructured":"Tonga GY, Saha K, Rotello VM (2014) 25th anniversary article: interfacing nanoparticles and biology: new strategies for biomedicine. Adv Mater 26:359\u2013370","journal-title":"Adv Mater"},{"key":"2284_CR64","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41427-021-00320-0","volume":"13","author":"X Zhang","year":"2021","unstructured":"Zhang X, Ma G, Wei W (2021) Simulation of nanoparticles interacting with a cell membrane: probing the structural basis and potential biomedical application. NPG Asia Mater 13:52","journal-title":"NPG Asia Mater"},{"key":"2284_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1533033818785329","volume":"17","author":"U Probst","year":"2018","unstructured":"Probst U, Fuhrmann I, Beyer L, Wiggermann P (2018) Electrochemotherapy as a new modality in interventional oncology: a review. Technol Cancer Res Treat 17:1\u201312","journal-title":"Technol Cancer Res Treat"},{"key":"2284_CR66","doi-asserted-by":"crossref","unstructured":"Fernandes P, O\u2019Donovan TR, McKenna SL, Forde PF (2019) Electrochemotherapy causes caspase-independent necrotic-like death in pancreatic cancer cells. Cancers 11:1177","DOI":"10.3390\/cancers11081177"},{"key":"2284_CR67","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1080\/00365521.2017.1346705","volume":"52","author":"D Ansari","year":"2017","unstructured":"Ansari D, Kristoffersson S, Andersson R, Bergenfeldt M (2017) The role of irreversible electroporation (IRE) for locally advanced pancreatic cancer: a systematic review of safety and efficacy. Scand J Gastroenterol 52:1165\u20131171","journal-title":"Scand J Gastroenterol"},{"key":"2284_CR68","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1080\/09553002.2020.1704300","volume":"96","author":"SN Jia","year":"2020","unstructured":"Jia SN, Wen FX, Gong TT, Li X et al (2020) A review on the efficacy and safety of iodine-125 seed implantation in unresectable pancreatic cancers. Int J Radiat Biol 96:383\u2013389","journal-title":"Int J Radiat Biol"},{"key":"2284_CR69","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s11547-018-0867-6","volume":"123","author":"Y Liu","year":"2018","unstructured":"Liu Y, Wang Y, Tang W, Jiang M et al (2018) Multiparametric MR imaging detects therapy efficacy of radioactive seeds brachytherapy in pancreatic ductal adenocarcinoma xenografts. Radiol Med 123:481\u2013488","journal-title":"Radiol Med"},{"key":"2284_CR70","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.4103\/0019-509X.172517","volume":"52","author":"B Liu","year":"2015","unstructured":"Liu B, Zhou T, Geng J, Zhang F et al (2015) Percutaneous computed tomography-guided iodine-125 seeds implantation for unresectable pancreatic cancer. Indian J Cancer 52:e69\u2013e74","journal-title":"Indian J Cancer"},{"key":"2284_CR71","doi-asserted-by":"publisher","first-page":"7307","DOI":"10.3390\/ijms21197307","volume":"21","author":"M Huber","year":"2020","unstructured":"Huber M, Brehm CU, Gress TM, Buchholz M et al (2020) The immune microenvironment in pancreatic cancer. Int J Mol Sci 21:7307","journal-title":"Int J Mol Sci"},{"key":"2284_CR72","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/ni.3206","volume":"16","author":"J Silke","year":"2015","unstructured":"Silke J, Rickard JA, Gerlic M (2015) The diverse role of RIP kinases in necroptosis and inflammation. Nat Immunol 16:689\u2013697","journal-title":"Nat Immunol"},{"key":"2284_CR73","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.3390\/cells9081823","volume":"9","author":"J Sprooten","year":"2020","unstructured":"Sprooten J, De Wijngaert P, Vanmeerbeek I, Martin S et al (2020) Necroptosis in Immuno-Oncology and cancer immunotherapy. Cells 9:1823","journal-title":"Cells"},{"key":"2284_CR74","doi-asserted-by":"publisher","first-page":"114413","DOI":"10.1016\/j.intimp.2025.114413","volume":"152","author":"Y Chen","year":"2025","unstructured":"Chen Y, Chen M, Chen H, Zhu JH et al (2025) Crosstalk patterns of necroptosis signaling and NLRP3 inflammasome in the colonic epithelium and its initial role in colitis. Int Immunopharmacol 152:114413","journal-title":"Int Immunopharmacol"},{"key":"2284_CR75","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.bbagen.2016.10.006","volume":"1861","author":"YS Wu","year":"2017","unstructured":"Wu YS, Chung I, Wong WF, Masamune A et al (2017) Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3\/Nrf2 pathway in pancreatic cancer cells. Biochim Biophys Acta Gen Subj 1861:296\u2013306","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"2284_CR76","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s40425-019-0734-6","volume":"7","author":"R Trovato","year":"2019","unstructured":"Trovato R, Fiore A, Sartori S, Can\u00e8 S et al (2019) Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3. J Immunother Cancer 7:255","journal-title":"J Immunother Cancer"},{"key":"2284_CR77","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1038\/s41388-020-01626-z","volume":"40","author":"H Chen","year":"2021","unstructured":"Chen H, Bian A, Yang LF, Yin X et al (2021) Targeting STAT3 by a small molecule suppresses pancreatic cancer progression. Oncogene 40:1440\u20131457","journal-title":"Oncogene"},{"key":"2284_CR78","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/j.jcmgh.2021.07.006","volume":"12","author":"SB Kemp","year":"2021","unstructured":"Kemp SB, Pasca di Magliano M, Crawford HC (2021) Myeloid cell mediated immune suppression in pancreatic cancer. Cell Mol Gastroenterol Hepatol 12:1531\u20131542","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2284_CR79","doi-asserted-by":"crossref","unstructured":"Li F, Chen J, Li Y, Wang W et al (2025) Oncolytic virus-induced IL-1\u03b2+ monocyte-IL-6+ CAF axis suppresses dendritic cell-mediated antitumor immunity in pancreatic cancer. J Immunother Cancer 13:e013175","DOI":"10.1136\/jitc-2025-013175"},{"key":"2284_CR80","doi-asserted-by":"publisher","first-page":"4510","DOI":"10.3390\/cancers13184510","volume":"13","author":"J Silke","year":"2021","unstructured":"Silke J, O\u2019Reilly LA (2021) NF-\u03baB and pancreatic cancer; chapter and verse. Cancers 13:4510","journal-title":"Cancers"},{"key":"2284_CR81","doi-asserted-by":"publisher","first-page":"5303","DOI":"10.1038\/s41598-019-41740-x","volume":"9","author":"AJ Marzoq","year":"2019","unstructured":"Marzoq AJ, Mustafa SA, Heidrich L, Hoheisel JD et al (2019) Impact of the secretome of activated pancreatic stellate cells on growth and differentiation of pancreatic tumour cells. Sci Rep 9:5303","journal-title":"Sci Rep"},{"key":"2284_CR82","doi-asserted-by":"publisher","first-page":"4271","DOI":"10.1038\/s41388-020-1289-1","volume":"39","author":"DD Cave","year":"2020","unstructured":"Cave DD, Guida MD, Costa V, Sevillano M et al (2020) TGF-\u03b21 secreted by pancreatic stellate cells promotes stemness and tumourigenicity in pancreatic cancer cells through L1CAM downregulation. Oncogene 39:4271\u20134285","journal-title":"Oncogene"},{"key":"2284_CR83","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1158\/0008-5472.CAN-24-4784","volume":"85","author":"YD Wu","year":"2025","unstructured":"Wu YD, Huang XX, Zhang HX, Pan Y et al (2025) TRAF3IP2-AS1 deficiency induces necroptosis to promote pancreatic cancer liver metastasis. Cancer Res 85:3292\u20133312","journal-title":"Cancer Res"},{"key":"2284_CR84","doi-asserted-by":"publisher","first-page":"e70788","DOI":"10.1002\/cam4.70788","volume":"14","author":"S Sigirli","year":"2025","unstructured":"Sigirli S, Karakas D (2025) Fibrotic fortresses and therapeutic frontiers: pancreatic stellate cells and the extracellular matrix in pancreatic cancer. Cancer Med 14:e70788","journal-title":"Cancer Med"},{"key":"2284_CR85","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s42003-022-03371-3","volume":"5","author":"LK Chan","year":"2022","unstructured":"Chan LK, Tsesmelis M, Gerstenlauer M, Leith\u00e4user F et al (2022) Functional IKK\/NF-\u03baB signaling in pancreatic stellate cells is essential to prevent autoimmune pancreatitis. Commun Biol 5:509","journal-title":"Commun Biol"},{"key":"2284_CR86","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/febs.15865","volume":"289","author":"K Liu","year":"2022","unstructured":"Liu K, Shen L, Wu M, Liu ZJ et al (2022) Structural insights into the activation of chemokine receptor CXCR2. FEBS J 289:386\u2013393","journal-title":"FEBS J"},{"key":"2284_CR87","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.canlet.2005.10.041","volume":"241","author":"MN Wente","year":"2006","unstructured":"Wente MN, Keane MP, Burdick MD, Friess H et al (2006) Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis. Cancer Lett 241:221\u2013227","journal-title":"Cancer Lett"},{"key":"2284_CR88","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.ccell.2016.04.014","volume":"29","author":"CW Steele","year":"2016","unstructured":"Steele CW, Karim SA, Leach JDG, Bailey P et al (2016) CXCR2 inhibition profoundly suppresses metastases and augments immunotherapy in pancreatic ductal adenocarcinoma. Cancer Cell 29:832\u2013845","journal-title":"Cancer Cell"},{"key":"2284_CR89","doi-asserted-by":"publisher","first-page":"e0228015","DOI":"10.1371\/journal.pone.0228015","volume":"15","author":"Y Ando","year":"2020","unstructured":"Ando Y, Ohuchida K, Otsubo Y, Kibe S et al (2020) Necroptosis in pancreatic cancer promotes cancer cell migration and invasion by release of CXCL5. PLoS One15:e0228015","journal-title":"PLoS One"},{"key":"2284_CR90","doi-asserted-by":"publisher","first-page":"6043","DOI":"10.1038\/s41467-024-50450-6","volume":"15","author":"CY Liao","year":"2024","unstructured":"Liao CY, Li G, Kang FP, Lin CF et al (2024) Necroptosis enhances \u2018don\u2019t eat me\u2019 signal and induces macrophage extracellular traps to promote pancreatic cancer liver metastasis. Nat Commun 15:6043","journal-title":"Nat Commun"},{"key":"2284_CR91","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/nature17403","volume":"532","author":"L Seifert","year":"2016","unstructured":"Seifert L, Werba G, Tiwari S, Giao Ly NN et al (2016) The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression. Nature 532:245\u2013249","journal-title":"Nature"},{"key":"2284_CR92","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.immuni.2021.01.012","volume":"54","author":"AJ Ozga","year":"2021","unstructured":"Ozga AJ, Chow MT, Luster AD (2021) Chemokines and the immune response to cancer. Immunity 54:859\u2013874","journal-title":"Immunity"},{"key":"2284_CR93","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA (2023) The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell 41:374\u2013403","journal-title":"Cancer Cell"},{"key":"2284_CR94","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.ccell.2015.02.015","volume":"27","author":"B Ruffell","year":"2015","unstructured":"Ruffell B, Coussens LM (2015) Macrophages and therapeutic resistance in cancer. Cancer Cell 27:462\u2013472","journal-title":"Cancer Cell"},{"key":"2284_CR95","doi-asserted-by":"publisher","first-page":"5839","DOI":"10.1158\/0008-5472.CAN-04-0465","volume":"64","author":"PC Rodriguez","year":"2004","unstructured":"Rodriguez PC, Quiceno DG, Zabaleta J, Ortiz B et al (2004) Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res 64:5839\u20135849","journal-title":"Cancer Res"},{"key":"2284_CR96","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/2045-824X-4-14","volume":"4","author":"MC Schmid","year":"2012","unstructured":"Schmid MC, Varner JA (2012) Myeloid cells in tumor inflammation. Vasc Cell 4:14","journal-title":"Vasc Cell"},{"key":"2284_CR97","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1126\/science.1232227","volume":"339","author":"LM Coussens","year":"2013","unstructured":"Coussens LM, Zitvoge L, AK Palucka (2013) Neutralizing tumor-promoting chronic inflammation: a magic bullet? Science 339:286\u2013291","journal-title":"Science"},{"key":"2284_CR98","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1158\/2159-8290.CD-15-1346","volume":"6","author":"MM Kaneda","year":"2016","unstructured":"Kaneda MM, Cappello P, Nguyen AV, Ralainirina N et al (2016) Macrophage PI3K\u03b3 drives pancreatic ductal adenocarcinoma progression. Cancer Discov 6:870\u2013885","journal-title":"Cancer Discov"},{"key":"2284_CR99","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.ccell.2018.10.006","volume":"34","author":"W Wang","year":"2018","unstructured":"Wang W, Marinis JM, Beal AM, Savadkar S et al (2018) RIP1 kinase drives Macrophage-Mediated adaptive immune tolerance in pancreatic cancer. Cancer Cell 34:757\u2013774.e7","journal-title":"Cancer Cell"},{"key":"2284_CR100","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/ni.1651","volume":"9","author":"S Yamasaki","year":"2008","unstructured":"Yamasaki S, Ishikawa E, Sakuma M, Hara H et al (2008) Mincle is an ITAM-coupled activating receptor that senses damaged cells. Nat Immunol 9:1179\u20131188","journal-title":"Nat Immunol"},{"key":"2284_CR101","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi L, Vitale I, Aaronson SA, Abrams JM et al (2018) Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. Cell Death Differ 25:486\u2013541","journal-title":"Cell Death Differ"},{"key":"2284_CR102","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"S Elmore","year":"2007","unstructured":"Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35:495\u2013516","journal-title":"Toxicol Pathol"},{"key":"2284_CR103","doi-asserted-by":"publisher","first-page":"4968","DOI":"10.3390\/ijms20194968","volume":"20","author":"N Kajarabille","year":"2019","unstructured":"Kajarabille N, Latunde-Dada GO (2019) Programmed cell-death by ferroptosis: antioxidants as mitigators. Int J Mol Sci 20:4968","journal-title":"Int J Mol Sci"},{"key":"2284_CR104","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.cell.2021.12.024","volume":"185","author":"N Rana","year":"2022","unstructured":"Rana N, Privitera G, Kondolf HC, Bulek K et al (2022) GSDMB is increased in IBD and regulates epithelial restitution\/repair independent of pyroptosis. Cell 185:283\u2013298.e17","journal-title":"Cell"},{"key":"2284_CR105","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.3390\/ijms22094642","volume":"22","author":"CA Juan","year":"2021","unstructured":"Juan CA, P\u00e9rez de la Lastra JM, Plou FJ, P\u00e9rez-Lebe\u00f1a E (2021) The chemistry of reactive oxygen species (ROS) revisited: outlining their role in biological macromolecules (DNA, lipids and Proteins) and induced pathologies. Int J Mol Sci 22:4642","journal-title":"Int J Mol Sci"},{"key":"2284_CR106","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.tcb.2015.01.001","volume":"25","author":"K Newton","year":"2015","unstructured":"Newton K (2015) RIPK1 and RIPK3: critical regulators of inflammation and cell death. Trends Cell Biol 25:347\u2013353","journal-title":"Trends Cell Biol"},{"key":"2284_CR107","doi-asserted-by":"publisher","first-page":"14329","DOI":"10.1038\/ncomms14329","volume":"8","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Su SS, Zhao S, Yang Z et al (2017) RIP1 autophosphorylation is promoted by mitochondrial ROS and is essential for RIP3 recruitment into necrosome. Nat Commun 8:14329","journal-title":"Nat Commun"},{"key":"2284_CR108","doi-asserted-by":"publisher","first-page":"34643","DOI":"10.1074\/jbc.M400078200","volume":"279","author":"EC Vaquero","year":"2004","unstructured":"Vaquero EC, Edderkaoui M, Pandol SJ, Gukovsky I et al (2004) Reactive oxygen species produced by NAD(P)H oxidase inhibit apoptosis in pancreatic cancer cells. J Biol Chem 279:34643\u201334654","journal-title":"J Biol Chem"},{"key":"2284_CR109","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1053\/j.gastro.2007.08.022","volume":"133","author":"JK Lee","year":"2007","unstructured":"Lee JK, Edderkaoui M, Truong P, Ohno I et al (2007) NADPH oxidase promotes pancreatic cancer cell survival via inhibiting JAK2 dephosphorylation by tyrosine phosphatases. Gastroenterology 133:1637\u20131648","journal-title":"Gastroenterology"},{"key":"2284_CR110","doi-asserted-by":"publisher","first-page":"5796","DOI":"10.1038\/onc.2015.35","volume":"34","author":"B Schenk","year":"2015","unstructured":"Schenk B, Fulda S (2015) Reactive oxygen species regulate Smac mimetic\/TNF\u03b1-induced necroptotic signaling and cell death. Oncogene 34:5796\u20135806","journal-title":"Oncogene"},{"key":"2284_CR111","doi-asserted-by":"crossref","unstructured":"Wang J, Wu Z, Zhu M, Zhao Y et al (2024) ROS induced pyroptosis in inflammatory disease and cancer. Front Immunol 15:1378990","DOI":"10.3389\/fimmu.2024.1378990"},{"key":"2284_CR112","doi-asserted-by":"publisher","first-page":"568","DOI":"10.4049\/immunohorizons.2100059","volume":"5","author":"RKS Malireddi","year":"2021","unstructured":"Malireddi RKS, Karki R, Sundaram B, Kancharana B et al (2021) Inflammatory cell death, PANoptosis, mediated by cytokines in diverse cancer lineages inhibits tumor growth. Immunohorizons 5:568\u2013580","journal-title":"Immunohorizons"},{"key":"2284_CR113","doi-asserted-by":"publisher","first-page":"101614","DOI":"10.1016\/j.genrep.2022.101614","volume":"27","author":"M Golbashirzadeh","year":"2022","unstructured":"Golbashirzadeh M, Heidari HR, Khosroushahi AY (2022) Molecular mechanisms of reactive oxygen species in regulated cell deaths: impact of ferroptosis in cancer therapy. Gene Rep 27:101614","journal-title":"Gene Rep"},{"key":"2284_CR114","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/S0140-6736(18)31541-1","volume":"392","author":"SC Palmer","year":"2018","unstructured":"Palmer SC, Strippoli GFM (2018) Metformin as first-line treatment for type 2 diabetes. Lancet 392:120","journal-title":"Lancet"},{"key":"2284_CR115","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1007\/s11095-010-0089-7","volume":"27","author":"S Shukla","year":"2010","unstructured":"Shukla S, Gupta S (2010) Apigenin: a promising molecule for cancer prevention. Pharm Res 27:962\u2013978","journal-title":"Pharm Res"},{"key":"2284_CR116","doi-asserted-by":"publisher","first-page":"14002","DOI":"10.1038\/s41598-021-93270-0","volume":"11","author":"MS Warkad","year":"2021","unstructured":"Warkad MS, Kim CH, Kang BG, Park SH et al (2021) Metformin-induced ROS upregulation as amplified by apigenin causes profound anticancer activity while sparing normal cells. Sci Rep 11:14002","journal-title":"Sci Rep"},{"key":"2284_CR117","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ccr.2014.12.002","volume":"301","author":"JC Pessoa","year":"2015","unstructured":"Pessoa JC, Etcheverry S, Gambino D (2015) Vanadium compounds in medicine. Coord Chem Rev 301:24\u201348","journal-title":"Coord Chem Rev"},{"key":"2284_CR118","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/00006676-198810000-00003","volume":"3","author":"ME Madden","year":"1988","unstructured":"Madden ME, Sarras MPJ (1988) Morphological and biochemical characterization of a human pancreatic ductal cell line (PANC- 1). Pancreas 3:512\u2013528","journal-title":"Pancreas"},{"key":"2284_CR119","doi-asserted-by":"publisher","first-page":"60324","DOI":"10.18632\/oncotarget.19454","volume":"8","author":"S Kowalski","year":"2017","unstructured":"Kowalski S, Ha\u0107 S, Wyrzykowski D, Zauszkiewicz-Pawlak A et al (2017) Selective cytotoxicity of vanadium complexes on human pancreatic ductal adenocarcinoma cell line by inducing necroptosis, apoptosis and mitotic catastrophe process. Oncotarget 8:60324\u201360341","journal-title":"Oncotarget"},{"key":"2284_CR120","doi-asserted-by":"publisher","first-page":"1900132","DOI":"10.1002\/adhm.201900132","volume":"8","author":"M Lan","year":"2019","unstructured":"Lan M, Zhao S, Liu W, Lee CS et al (2019) Photosensitizers for photodynamic therapy. Adv Healthc Mater 8:1900132","journal-title":"Adv Healthc Mater"},{"key":"2284_CR121","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s43630-022-00347-4","volume":"22","author":"DRQ de Almeida","year":"2023","unstructured":"de Almeida DRQ, Santos AFD, Wailemann RAM, Terra LF et al (2023) Necroptosis activation is associated with greater methylene blue-photodynamic therapy-induced cytotoxicity in human pancreatic ductal adenocarcinoma cells. Photochem Photobiol Sci 22:729\u2013744","journal-title":"Photochem Photobiol Sci"},{"key":"2284_CR122","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1038\/bjc.2014.95","volume":"110","author":"MT Huggett","year":"2014","unstructured":"Huggett MT, Jermyn M, Gillams A, Illing R et al (2014) Phase I\/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer. Br J Cancer 110:1698\u20131704","journal-title":"Br J Cancer"},{"key":"2284_CR123","doi-asserted-by":"crossref","unstructured":"Santofimia-Casta\u00f1o P, Iovanna J (2021) Combating pancreatic cancer chemoresistance by triggering multiple cell death pathways. Pancreatology 21:522\u2013529","DOI":"10.1016\/j.pan.2021.01.010"},{"key":"2284_CR124","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ceb.2020.02.004","volume":"63","author":"R Schwarzer","year":"2020","unstructured":"Schwarzer R, Laurien L, Pasparakis M (2020) New insights into the regulation of apoptosis, necroptosis, and pyroptosis by receptor interacting protein kinase 1 and caspase-8. Curr Opin Cell Biol 63:186\u2013193","journal-title":"Curr Opin Cell Biol"},{"key":"2284_CR125","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1172\/JCI127223","volume":"129","author":"P Santofimia-Casta\u00f1o","year":"2019","unstructured":"Santofimia-Casta\u00f1o P, Xia Y, Lan W, Zhou Z et al (2019) Ligand-based design identifies a potent NUPR1 inhibitor exerting anticancer activity via necroptosis. J Clin Invest 129:2500\u20132513","journal-title":"J Clin Invest"},{"key":"2284_CR126","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.3390\/cancers14102486","volume":"14","author":"T Koltai","year":"2022","unstructured":"Koltai T, Reshkin SJ, Carvalho TMA, Molfetta DD et al (2022) Resistance to gemcitabine in pancreatic ductal adenocarcinoma: a physiopathologic and pharmacologic review. Cancers 14:2486","journal-title":"Cancers"},{"key":"2284_CR127","doi-asserted-by":"publisher","first-page":"7276","DOI":"10.18632\/oncotarget.27399","volume":"10","author":"L Xie","year":"2019","unstructured":"Xie L, Xia L, Klaiber U, Sachsenmaier M et al (2019) Effects of neoadjuvant FOLFIRINOX and gemcitabine-based chemotherapy on cancer cell survival and death in patients with pancreatic ductal adenocarcinoma. Oncotarget 10:7276\u20137287","journal-title":"Oncotarget"},{"key":"2284_CR128","first-page":"e19361","volume":"13","author":"C Nitipir","year":"2021","unstructured":"Nitipir C, Vrabie R, Parosanu AI, Tulin R et al (2021) Clinical impact of the administration of FOLFIRINOX beyond six months in advanced pancreatic adenocarcinoma: a cohort study. Cureus 13:e19361","journal-title":"Cureus"},{"key":"2284_CR129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yexcr.2015.10.005","volume":"339","author":"S Pietkiewicz","year":"2015","unstructured":"Pietkiewicz S, Eils R, Krammer PH, Giese N et al (2015) Combinatorial treatment of CD95L and gemcitabine in pancreatic cancer cells induces apoptotic and RIP1-mediated necroptotic cell death network. Exp Cell Res 339:1\u20139","journal-title":"Exp Cell Res"},{"key":"2284_CR130","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/S0022-2275(20)31171-8","volume":"42","author":"PN Duchateau","year":"2001","unstructured":"Duchateau PN, Pullinger CR, Cho MH, Eng C et al (2001) Apolipoprotein L gene family: tissue-specific expression, splicing, promoter regions; discovery of a new gene. J Lipid Res 42:620\u2013630","journal-title":"J Lipid Res"},{"key":"2284_CR131","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1158\/1541-7786.21.3.1","volume":"3","author":"Z Liu","year":"2005","unstructured":"Liu Z, Lu H, Jiang Z, Pastuszyn A et al (2005) Apolipoprotein L6, a novel proapoptotic Bcl-2 homology 3-only protein, induces mitochondria-mediated apoptosis in cancer cells. Mol Cancer Res 3:21\u201331","journal-title":"Mol Cancer Res"},{"key":"2284_CR132","doi-asserted-by":"crossref","unstructured":"Liu K, Chen Y, Li B, Li Y et al (2023) Upregulation of Apolipoprotein L6 improves tumor immunotherapy by inducing immunogenic cell death. Biomolecules 13:415","DOI":"10.3390\/biom13030415"},{"key":"2284_CR133","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1016\/j.csbj.2023.03.037","volume":"21","author":"SY Lu","year":"2023","unstructured":"Lu SY, Hua J, Liu J, Wei MY et al (2023) A new approach: evaluation of necroptosis and immune status enables prediction of the tumor microenvironment and treatment targets in pancreatic cancer. Comput Struct Biotechnol J 21:2419\u20132433","journal-title":"Comput Struct Biotechnol J"},{"key":"2284_CR134","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10620-020-06183-9","volume":"66","author":"J Wu","year":"2021","unstructured":"Wu J, Cai J (2021) Dilemma and challenge of immunotherapy for pancreatic cancer. Dig Dis Sci 66:359\u2013368","journal-title":"Dig Dis Sci"},{"key":"2284_CR135","doi-asserted-by":"publisher","first-page":"869","DOI":"10.18632\/aging.203846","volume":"14","author":"Z Wu","year":"2022","unstructured":"Wu Z, Huang X, Cai M, Huang P et al (2022) Novel necroptosis-related gene signature for predicting the prognosis of pancreatic adenocarcinoma. Aging 14:869\u2013891","journal-title":"Aging"},{"key":"2284_CR136","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12672-022-00477-2","volume":"13","author":"J Ma","year":"2022","unstructured":"Ma J, Jin Y, Gong B, Li L et al (2022) Pan-cancer analysis of necroptosis-related gene signature for the identification of prognosis and immune significance. Discov Oncol 13:17","journal-title":"Discov Oncol"},{"key":"2284_CR137","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.3390\/biomedicines11061738","volume":"11","author":"H Liu","year":"2023","unstructured":"Liu H, Li Z, Zhang L, Zhang M et al (2023) Necroptosis-related prognostic model for pancreatic carcinoma reveals its invasion and metastasis potential through hybrid EMT and immune escape. Biomedicines 11:1738","journal-title":"Biomedicines"},{"key":"2284_CR138","doi-asserted-by":"publisher","first-page":"9737587","DOI":"10.1155\/2022\/9737587","volume":"2022","author":"C Ding","year":"2022","unstructured":"Ding C, Yu Z, Zhu J, Li X et al (2022) Construction and validation of a necroptosis-related gene signature for predicting prognosis and tumor microenvironment of pancreatic cancer. Dis Markers 2022:9737587","journal-title":"Dis Markers"},{"key":"2284_CR139","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.3390\/ijms19103028","volume":"19","author":"C Walker","year":"2018","unstructured":"Walker C, Mojares E, del R\u00edo Hern\u00e1ndez A (2018) Role of extracellular matrix in development and cancer progression. Int J Mol Sci 19:3028","journal-title":"Int J Mol Sci"},{"key":"2284_CR140","doi-asserted-by":"publisher","first-page":"4265","DOI":"10.1007\/s10238-023-01229-4","volume":"23","author":"SO Imodoye","year":"2023","unstructured":"Imodoye SO, Adedokun KA (2023) EMT-induced immune evasion: connecting the dots from mechanisms to therapy. Clin Exp Med 23:4265\u20134287","journal-title":"Clin Exp Med"},{"key":"2284_CR141","doi-asserted-by":"publisher","first-page":"107709","DOI":"10.1016\/j.pharmthera.2020.107709","volume":"219","author":"T Tang","year":"2021","unstructured":"Tang T, Cheng X, Truong B, Sun L et al (2021) Molecular basis and therapeutic implications of CD40\/CD40L immune checkpoint. Pharmacol Ther 219:107709","journal-title":"Pharmacol Ther"},{"key":"2284_CR142","doi-asserted-by":"publisher","first-page":"4795","DOI":"10.7150\/thno.30988","volume":"9","author":"M Liu","year":"2019","unstructured":"Liu M, Zhong J, Zeng Z, Huang K et al (2019) Hypoxia-induced feedback of HIF-1\u03b1 and lncRNA-CF129 contributes to pancreatic cancer progression through stabilization of p53 protein. Theranostics 9:4795\u20134810","journal-title":"Theranostics"},{"key":"2284_CR143","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","volume":"24","author":"JS Mattick","year":"2023","unstructured":"Mattick JS, Amaral PP, Carninci P, Carpenter S et al (2023) Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol 24:430\u2013447","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2284_CR144","doi-asserted-by":"publisher","first-page":"e2201889","DOI":"10.1002\/advs.202201889","volume":"9","author":"Q Wang","year":"2022","unstructured":"Wang Q, Chen C, Xu X, Shu C et al (2022) APAF1-binding long noncoding RNA promotes tumor growth and multidrug resistance in gastric cancer by blocking apoptosome assembly. Adv Sci (Weinh) 9:e2201889","journal-title":"Adv Sci (Weinh)"},{"key":"2284_CR145","doi-asserted-by":"publisher","first-page":"e2201210","DOI":"10.1002\/advs.202201210","volume":"9","author":"B Zhang","year":"2022","unstructured":"Zhang B, Thorne RF, Zhang P, Wu M et al (2022) Vanguard is a glucose deprivation-responsive long non-coding RNA essential for chromatin remodeling-reliant DNA repair. Adv Sci (Weinh) 9:e2201210","journal-title":"Adv Sci (Weinh)"},{"key":"2284_CR146","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12943-022-01647-0","volume":"21","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Liu X, Wang Y, Lai S et al (2022) The m6A demethylase ALKBH5-mediated upregulation of DDIT4-AS1 maintains pancreatic cancer stemness and suppresses chemosensitivity by activating the mTOR pathway. Mol Cancer 21:174","journal-title":"Mol Cancer"},{"key":"2284_CR147","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s13046-020-01687-8","volume":"39","author":"H Zhang","year":"2020","unstructured":"Zhang H, Zhu C, He Z, Chen S et al (2020) LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p\/STAT1\/PD-L1 axis. J Exp Clin Cancer Res 39:179","journal-title":"J Exp Clin Cancer Res"},{"key":"2284_CR148","first-page":"411","volume":"13","author":"R Harari-Steinfeld","year":"2021","unstructured":"Harari-Steinfeld R, Gefen M, Simerzin A, Zorde-Khvalevsky E et al (2021) The lncRNA H19-derived microRNA-675 promotes liver necroptosis by targeting FADD. Cancers 13:411","journal-title":"Cancers(Basel)"},{"key":"2284_CR149","doi-asserted-by":"publisher","first-page":"989719","DOI":"10.3389\/fgene.2022.989719","volume":"13","author":"Y Ye","year":"2022","unstructured":"Ye Y, Zhao Q, Wu Y, Wang G et al (2022) Construction of a cancer-associated fibroblasts-related long non-coding RNA signature to predict prognosis and immune landscape in pancreatic adenocarcinoma. Front Genet 13:989719","journal-title":"Front Genet"},{"key":"2284_CR150","doi-asserted-by":"publisher","first-page":"7405","DOI":"10.1007\/s11033-023-08663-3","volume":"50","author":"Y Xiong","year":"2023","unstructured":"Xiong Y, Kong X, Fang K, Sun G et al (2023) Establishment of a novel signature to predict prognosis and immune characteristics of pancreatic cancer based on necroptosis-related long non-coding RNA. Mol Biol Rep 50:7405\u20137419","journal-title":"Mol Biol Rep"},{"key":"2284_CR151","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v039.i05","volume":"39","author":"N Simon","year":"2011","unstructured":"Simon N, Friedman J, Hastie T, Tibshirani R (2011) Regularization paths for Cox\u2019s proportional hazards model via coordinate descent. J Stat Softw 39:1\u201313","journal-title":"J Stat Softw"},{"key":"2284_CR152","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1007\/s43032-022-01155-y","volume":"30","author":"Z Yang","year":"2023","unstructured":"Yang Z, Li J, Tang Y, Zou L (2023) Identification and validation a necroptosis-related prognostic signature in cervical cancer. Reprod Sci 30:2003\u20132015","journal-title":"Reprod Sci"},{"key":"2284_CR153","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12935-022-02494-1","volume":"22","author":"L Li","year":"2022","unstructured":"Li L, Li P, Zhang W, Zhou H et al (2022) FERMT1 contributes to the migration and invasion of nasopharyngeal carcinoma through epithelial-mesenchymal transition and cell cycle arrest. Cancer Cell Int 22:70","journal-title":"Cancer Cell Int"},{"key":"2284_CR154","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1186\/s12903-021-01955-9","volume":"21","author":"X Wang","year":"2021","unstructured":"Wang X, Chen Q (2021) FERMT1 knockdown inhibits oral squamous cell carcinoma cell epithelial-mesenchymal transition by inactivating the PI3K\/AKT signaling pathway. BMC Oral Health 21:598","journal-title":"BMC Oral Health"},{"key":"2284_CR155","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1038\/onc.2016.339","volume":"36","author":"CC Liu","year":"2017","unstructured":"Liu CC, Cai DL, Sun F, Wu ZH et al (2017) FERMT1 mediates epithelial-mesenchymal transition to promote colon cancer metastasis via modulation of \u03b2-catenin transcriptional activity. Oncogene 36:1779\u20131792","journal-title":"Oncogene"},{"key":"2284_CR156","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1080\/15384047.2020.1792218","volume":"21","author":"H Fan","year":"2020","unstructured":"Fan H, Zhang S, Zhang Y, Liang W et al (2020) FERMT1 promotes gastric cancer progression by activating the NF-\u03baB pathway and predicts poor prognosis. Cancer Biol Ther 21:815\u2013825","journal-title":"Cancer Biol Ther"},{"key":"2284_CR157","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.3390\/biom11081082","volume":"11","author":"SS Wang","year":"2021","unstructured":"Wang SS, Xu J, Ji KY, Hwang CI (2021) Epigenetic alterations in pancreatic cancer metastasis. Biomolecules 11:1082","journal-title":"Biomolecules"},{"key":"2284_CR158","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1242\/jcs.161190","volume":"129","author":"E Rognoni","year":"2016","unstructured":"Rognoni E, Ruppert R, F\u00e4ssler R (2016) The kindlin family: functions, signaling properties and implications for human disease. J Cell Sci 129:17\u201327","journal-title":"J Cell Sci"},{"key":"2284_CR159","doi-asserted-by":"publisher","first-page":"734","DOI":"10.3390\/genes14030734","volume":"14","author":"Q Wu","year":"2023","unstructured":"Wu Q, Li J, Wang P, Peng Q et al (2023) FERMT1 is a prognostic marker involved in immune infiltration of pancreatic adenocarcinoma correlating with m6A modification and necroptosis. Genes 14:734","journal-title":"Genes"},{"key":"2284_CR160","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1084\/jem.20101876","volume":"208","author":"L De Monte","year":"2011","unstructured":"De Monte L, Reni M, Tassi E, Clavenna D et al (2011) Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer. J Exp Med 208:469\u2013478","journal-title":"J Exp Med"},{"key":"2284_CR161","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3390\/cancers13040684","volume":"13","author":"L Della Torre","year":"2021","unstructured":"Della Torre L, Nebbioso A, Stunnenberg HG, Martens JHA et al (2021) The role of necroptosis: biological relevance and its involvement in cancer. Cancers 13:684","journal-title":"Cancers"},{"key":"2284_CR162","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41419-023-05691-6","volume":"14","author":"K Ye","year":"2023","unstructured":"Ye K, Chen Z, Xu Y (2023) The double-edged functions of necroptosis. Cell Death Dis 14:163","journal-title":"Cell Death Dis"},{"key":"2284_CR163","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1038\/s41467-020-16887-1","volume":"11","author":"AL Samson","year":"2020","unstructured":"Samson AL, Zhang Y, Geoghegan ND, Gavin XJ et al (2020) MLKL trafficking and accumulation at the plasma membrane control the kinetics and threshold for necroptosis. Nat Commun 11:3151","journal-title":"Nat Commun"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02284-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-026-02284-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02284-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T14:04:28Z","timestamp":1779285868000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-026-02284-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":163,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2284"],"URL":"https:\/\/doi.org\/10.1007\/s10495-026-02284-4","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"23 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"131"}}